Schedule 13G ownership disclosure
AKARI THERAPEUTICS PLC
Ordinary Shares · CUSIP: 00972G405
Event date: 2026-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Bank of Montreal
Shares: 1,095,200,000 · Class: 0.78%
- BANK OF MONTREAL HOLDING INC.
Shares: 1,095,200,000 · Class: 0.78%
- BMO NESBITT BURNS INC.
Shares: 1,095,200,000 · Class: 0.78%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000927971-26-000112
- Form type
- SCHEDULE 13G/A
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Nov 12, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership